Algo version: 0.98b
Kingworld Medicines Group is listed at the HKSE Exchange
Kingworld Medicines Group [1110.HK]
HKSE Sector: Healthcare Industry:Pharmaceutical Retailers

Is Kingworld Medicines Group stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Kingworld Medicines Group pays dividends. Last time was Friday 28th of June 2024 where the investors holding the stock on Monday 3rd of June 2024 were paid HKD0.0338 per share. Over the last 15 times between 2011 and 2024, Kingworld Medicines Group has paid HKD0.4215 with an average of HKD0.03 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Kingworld Medicines Group 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD1.010, you would have made a loss of HKD-0.500 per share or -49.50%

No, the average daily trading liquidity for Kingworld Medicines Group is HKD1.14 million. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Kingworld Medicines Group has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.12, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 3.53%, which is challenging.

We have calculated the inflation risk for Kingworld Medicines Group to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.